Biotech: Biologics and cell therapy products

3P Biopharmaceuticals has the GMP (Good Manufacturing Practices) certification issued by the AEMPS for the manufacture and release of biological active substances, the release of biological drugs and the release of sterile products for both human and veterinary use and for the manufacture and release of cell therapy product: human allogeneic adult stem cells extracted from hearth tissue an "in vitro“ expanded.

3P Bio

/3P Bio
­

About 3P Bio

This author has not yet filled in any details.
So far 3P Bio has created 241 blog entries.
16 05, 2018

BIO INTERNATIONAL CONVENTION 2018

May 16th, 2018|Events, News|

Meet us at BIO 2018, the largest global event for the biotechnology industry.

We are exhibiting at booth #543 located into the Spanish pavilion.

Would you like to know more about our solutions? Join our company presentation on Monday 4th at 14:30 at theater 4.

Contact now our team to preschedule a meeting!

//

25 04, 2018

Dámaso Molero, General Manager at 3P, elected advisor to support the European Commission

April 25th, 2018|News|

Mr.Molero joins the High Level Industrial Roundtable “Industry 2030”
Pamplona 25th April 2018. Dámaso Molero, General Manager at 3P Biopharmaceuticals, has been recently elected as advisor by the European Commission. Mr. Molero has joined the group of 20 experts that is advising the Commission in the High Level Industrial Roundtable “Industry 2030”.

The Commission has selected the […]

21 03, 2018

3P Biopharmaceuticals and Intervacc complete manufacturing agreement

March 21st, 2018|News|

3P Biopharmaceuticals and Intervacc complete manufacturing agreement for new vaccine against equine strangles

3P Biopharmaceuticals and the Swedish company Intervacc have now completed negotiations and signed the agreement for contract manufacturing of Strangvac®. The agreement means that the production and documentation of the important validation batches required for registration of the new recombinant vaccine against equine […]

19 03, 2018

Free Webinar: high-throughput media and feed screening for cell culture process optimization with ambr®15

March 19th, 2018|News|

High-throughput media and feed screening for cell culture process optimization with multi-parallel micro bioreactors
Join our next webinar with our USP Development:  Specialist Dr Marta Ruiz Guillén.

She will present the methods and results from performing media and feed screening evaluations in ambr® 15 with CHO-S cell line producing monoclonal antibodies and demonstrate the effectiveness of ambr […]

13 03, 2018

INTERPHEX 2018

March 13th, 2018|Events, News|

Our team to attend INTERPHEX next April.

What is INTERPHEX?

For 39 years, INTERPHEX has proven to be the place to find all of the State-of-the-Art Solutions you need to Cost Effectively Develop and Manufacture Quality Product. INTERPHEX is the premier pharmaceutical, biotechnology, and device development and manufacturing event where you can “Experience Science through Commercialization”. Based […]